Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
株式のランク #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
株価
$0.0202
最終同期: 2024-11-19
時価総額
$44.67K
変化(1日)
-0.49%
変化(1年)
0.00%
IL
取引 Notable Labs, Ltd. (NTBL)

カテゴリー

Notable Labs, Ltd.(NTBL)のP/E比率
August 2026 時点のP/E比率 TTM -0.05
Notable Labs, Ltd. の最新の財務報告および株価によると、現在の P/E (TTM) は -0.05 です。2022 年末時点での P/E は -0.65 でした。
Notable Labs, Ltd. の P/E 比率の履歴(2015 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) -0.05 -86.68%
2023 -0.37 -43.36%
2022 -0.65 -99.79%
2021 -313.78 127.40%
2020 -137.98 26.10%
2019 -109.42 99.99%
2018 -54.71 -91.85%
2017 -671.58 153.53%
2016 -264.89 5.47%
2015 -251.14 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
28.05 -56,992.90%
US
31.14 -63,272.82%
NL
- -
CH
- -
KR
19.30 -39,245.44%
BE
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。